Published in AIDS Weekly, September 30th, 1996
This applies to T-cell lines and preliminary results indicate that some protection may also be achieved in gene-modified T cells from uninfected individuals. Further studies clearly need to be performed to confirm these observations.
The potential value of using gene-modified T lymphocytes to suppress HIV replication is currently being studied by several investigators in the US and Europe. For the past years researchers at Duke University, Durham, North Carolina, funded by the NIH have studied several...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.